George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,705 shares at $627.50 ($1.1M) on 2021-08-16, disclosed to the SEC on 2021-08-17.
Open-market sale of $1.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $627.50 | 1,000 | $628K | 58.6% |
| 2 | $630.00 | 705 | $444K | 41.4% |
| Total | $628.53 avg | 1,705 | $1.1M | 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |